Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11756165rdf:typepubmed:Citationlld:pubmed
pubmed-article:11756165lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:11756165lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:11756165lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:11756165lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:11756165lifeskim:mentionsumls-concept:C0292863lld:lifeskim
pubmed-article:11756165lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:11756165lifeskim:mentionsumls-concept:C0086816lld:lifeskim
pubmed-article:11756165lifeskim:mentionsumls-concept:C0205224lld:lifeskim
pubmed-article:11756165lifeskim:mentionsumls-concept:C0032190lld:lifeskim
pubmed-article:11756165pubmed:issue1lld:pubmed
pubmed-article:11756165pubmed:dateCreated2001-12-28lld:pubmed
pubmed-article:11756165pubmed:abstractTextPlatelet adhesion and aggregation at sites of vascular injury are critically dependent on the interaction between von Willebrand factor (VWF) and 2 major platelet adhesion receptors, glycoprotein (GP) Ib/V/IX and integrin alpha(IIb)beta(3). GP Ib/V/IX binding to VWF mediates platelet tethering and translocation, whereas activation of integrin alpha(IIb)beta(3) promotes cell arrest. To date, the signaling pathways used by the VWF-GP Ib/V/IX interaction to promote activation of integrin alpha(IIb)beta(3), particularly under shear, have remained poorly defined. In this study, the potential involvement of type 1 phosphoinositide (PI) 3-kinases in this process was investigated. Results show that platelet adhesion and spreading on immobilized VWF results in a specific increase in the PI 3-kinase lipid product, PtdIns(3,4)P(2). Under static conditions, inhibiting PI 3-kinase with LY294002 or wortmannin did not prevent platelet adhesion, integrin alpha(IIb)beta(3) activation, or platelet spreading although it significantly delayed the onset of these events. In contrast, PI 3-kinase inhibition under shear dramatically reduced both platelet adhesion and spreading. Real-time analysis of intracellular calcium demonstrated that under static conditions inhibiting PI 3-kinase delayed the onset of intracellular fluxes in adherent platelets, but did not affect the final magnitude of the calcium response. However, under shear, inhibiting PI 3-kinase dramatically reduced intracellular calcium mobilization and integrin alpha(IIb)beta(3) activation, resulting in impaired thrombus growth. The studies demonstrate a shear-dependent role for PI 3-kinase in promoting platelet adhesion on immobilized VWF. Under static conditions, platelets appear to mobilize intracellular calcium through both PI 3-kinase-dependent and -independent mechanisms, whereas under shear PI 3-kinase is indispensable for VWF-induced calcium release.lld:pubmed
pubmed-article:11756165pubmed:languageenglld:pubmed
pubmed-article:11756165pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11756165pubmed:statusMEDLINElld:pubmed
pubmed-article:11756165pubmed:monthJanlld:pubmed
pubmed-article:11756165pubmed:issn0006-4971lld:pubmed
pubmed-article:11756165pubmed:authorpubmed-author:SalemHatem...lld:pubmed
pubmed-article:11756165pubmed:authorpubmed-author:JacksonShaun...lld:pubmed
pubmed-article:11756165pubmed:authorpubmed-author:YapCindy LCLlld:pubmed
pubmed-article:11756165pubmed:authorpubmed-author:DopheideSacha...lld:pubmed
pubmed-article:11756165pubmed:authorpubmed-author:AndersonKaren...lld:pubmed
pubmed-article:11756165pubmed:authorpubmed-author:HughanSascha...lld:pubmed
pubmed-article:11756165pubmed:issnTypePrintlld:pubmed
pubmed-article:11756165pubmed:day1lld:pubmed
pubmed-article:11756165pubmed:volume99lld:pubmed
pubmed-article:11756165pubmed:ownerNLMlld:pubmed
pubmed-article:11756165pubmed:authorsCompleteYlld:pubmed
pubmed-article:11756165pubmed:pagination151-8lld:pubmed
pubmed-article:11756165pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:meshHeadingpubmed-meshheading:11756165...lld:pubmed
pubmed-article:11756165pubmed:year2002lld:pubmed
pubmed-article:11756165pubmed:articleTitleEssential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3).lld:pubmed
pubmed-article:11756165pubmed:affiliationAustralian Centre for Blood Diseases, Department of Medicine, Monash Medical School, Box Hill Hospital, Victoria, Australia.lld:pubmed
pubmed-article:11756165pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11756165pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11756165lld:pubmed